Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

Overview of attention for article published in Molecular Neurodegeneration, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 867)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 2,909 followers.

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and… https://t.co/snEWjGqs3B

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and the... https://t.co/wDeyljlcK6

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and… https://t.co/2Y8OJjR4aa

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and… https://t.co/pUlCMF1P39

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.